Manchester, New Hampshire

Manchester has emerged as a premier global hub for regenerative medicine and advanced biomanufacturing, anchored by the historic Millyard district.

At the center of this ecosystem is the Advanced Regenerative Manufacturing Institute (ARMI) and its BioFabUSA program, which leads the world in scaling the production of engineered tissues and organs.

The city's biotechnology sector is bolstered by a collaborative network of over 1,000 life sciences companies across the region, specializing in cell-based therapies and precision medicine.

Manchester is also a center for medical device innovation, home to industry pioneers like DEKA Research & Development, which focuses on transformative healthcare technologies such as revolutionary drug delivery and dialysis systems.

The city’s healthcare innovation landscape is further strengthened by the Biotechnology Innovation Center (BIC) at UNH Manchester, providing critical wet lab space and R&D infrastructure for startups.

Academic research excellence is driven by the University of New Hampshire (UNH) and Manchester Community College, ensuring a robust pipeline of specialized talent through the ReGen Valley workforce initiative.

Global pharmaceutical leaders and CDMOs maintain a significant presence in the area, leveraging New Hampshire's favorable regulatory environment and proximity to Boston’s biotech corridor.

This integrated ecosystem facilitates seamless clinical collaboration and "lab-to-bedside" technology transfer.